Lupin to set up 100 diagnostic labs and 1,000 collection centres in 5 yrs

Announced foray into fragmented diagnostic business where organised chains have less than 20% share of overall business

Lupin, Boehringer Ingelheim ink $700-mn deal for anti-cancer drug
Aneesh Phadnis Mumbai
1 min read Last Updated : Dec 10 2021 | 11:59 PM IST

Don't want to miss the best from Business Standard?

Lupin plans to set up over a hundred laboratories and a thousand franchisee-based collection centres as it aims to become among the top five diagnostic chains in the country.

The Mumbai-headquartered pharmaceutical company announced its foray in diagnostic business on Friday. The diagnostic sector is fragmented and organised chains have less than 20 per cent share of the overall business. A late entrant in the space, Lupin hopes to scale up the business leveraging its trust with health care professionals and with unique features such as temperature-controlled movement of samples, smart and interactive test reports among others.

Lupin Diagnostics will enable customers across India to obtain more accurate results with personalised insights, said Lupin’s managing director Nitin Gupta.  

So far the company has set one national reference laboratory in Navi Mumbai and expects to operationalize eleven laboratories in East and West India in the current fiscal.

Lupin’s India region president (formulations) Rajeev Sibal said the company will use a combination of organic growth and acquisitions to achieve a pan Indian presence. The business is being internally funded and there is no dearth of resources, he said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Lupinpharmaceutical firmsDiagnostic

Next Story